Company intelligence / Profile preview

Scion NeuroStim

Durham, North Carolina, United Statesscionneurostim.com ↗

Ownership: Private
Development stage: Commercial

Overview

Scion NeuroStim has developed a non-invasive, home-use neurostimulation device targeting brainstem nuclei to treat non-motor symptoms of Parkinson's disease. The company focuses on improving quality of life for patients with central nervous system diseases through innovative neuromodulation technologies. Early-stage development includes multiple patents related to caloric vestibular stimulation and ear/auditory-based therapies. No published clinical trial results or commercial products yet.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Scion NeuroStim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scion NeuroStim.

Explore the full profile